Privium Fund Management B.V.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 11, 2025), Privium Fund Management B.V. reported 59 stock positions worth $437.0 million. Its top holding was Tesla (TSLA) at 20.3% of the portfolio, followed by Spotify Technology (SPOT, 14.8%) and Shopify Class A (SHOP, 10.1%). Compared with Q3 2024, it opened 5 new positions, sold out of 28, added to 24 and reduced 15. The biggest buy was Tesla (TSLA, shares +2%) and the biggest sale Ast Spacemobile (ASTS, shares −86%).
- Most Recent 13F
- Q2 2026
- Location
- AMSTERDAM, P7
- CIK
- 0001795097
- Portfolio Value
- $437.0M (Q4 2024)
- SEC Filing
- 0001754960-25-000124 ↗ filed Feb 11, 2025
Holdings Value
Holdings 59 stocks · $437.0M
| TSLA Tesla Inc. | 20.33% | 220,000 | $88.8M | Add +1.9% |
| SPOT Spotify Technology SA | 14.85% | 145,000 | $64.9M | Reduce -2.7% |
| SHOP Shopify Inc. Class A | 10.10% | 415,000 | $44.1M | No change |
| AMZN Amazon.com Inc. | 7.08% | 141,000 | $30.9M | No change |
| PLTR Palantir Technologies Inc. Class A | 6.40% | 370,000 | $28.0M | Reduce -22.1% |
| SE Sea Ltd.-ADR | 5.10% | 210,000 | $22.3M | No change |
| PRQR Proqr Therapeutics NV | 3.02% | 4,985,633 | $13.2M | Reduce -11.5% |
| QURE Uniqure NV | 3.00% | 742,162 | $13.1M | Reduce -0.4% |
| SNOW Snowflake Inc. | 2.65% | 75,000 | $11.6M | Reduce -21.1% |
| RARE Ultragenyx Pharmaceutical Inc. | 2.49% | 258,380 | $10.9M | Add +6.5% |
| NVDA Nvidia Corp. | 2.24% | 73,000 | $9.8M | No change |
| IONS Ionis Pharmaceuticals Inc. | 2.13% | 266,794 | $9.3M | Add +6.4% |
| ITCI Intra-Cellular Therapies Inc. | 1.86% | 97,154 | $8.1M | Reduce -17.6% |
| MRK Merck & Co. Inc. | 1.65% | 72,611 | $7.2M | Add +20.8% |
| ARWR Arrowhead Pharmaceuticals Inc. | 1.64% | 380,586 | $7.2M | Add +14.2% |
| NET Cloudflare Inc. Class A | 1.48% | 60,000 | $6.5M | No change |
| SMR Nuscale Power Corp. | 1.48% | 360,001 | $6.5M | New |
| AXSM Axsome Therapeutics Inc. | 1.21% | 62,232 | $5.3M | Reduce -22.4% |
| RCKT Rocket Pharmaceuticals Inc. | 1.14% | 397,650 | $5.0M | Add +34.9% |
| ZLAB Zai Lab Ltd.-ADR | 1.11% | 185,062 | $4.8M | Reduce -14.2% |
| ARQT Arcutis Biotherapeutics Inc. | 1.04% | 325,709 | $4.5M | New |
| MRNA Moderna Inc. | 0.78% | 82,476 | $3.4M | Add +103.7% |
| CPNG Coupang Inc. | 0.71% | 141,900 | $3.1M | Reduce -29.7% |
| ACAD Acadia Pharmaceuticals Inc. | 0.62% | 148,400 | $2.7M | No change |
| ROIV Roivant Sciences Ltd. | 0.58% | 215,506 | $2.5M | Reduce -55.5% |
| ASTS Ast Spacemobile Inc. | 0.54% | 111,500 | $2.4M | Reduce -86.4% |
| MSFT Microsoft Corp. | 0.48% | 5,000 | $2.1M | Reduce -50.0% |
| KRYS Krystal Biotech Inc. | 0.33% | 9,250 | $1.4M | Add +45.7% |
| CRSP Crispr Therapeutics AG | 0.32% | 34,997 | $1.4M | Add +15.3% |
| MGTX Meiragtx Holdings PLC | 0.31% | 225,078 | $1.4M | Add +5.2% |
| ABEV Ambev SA-ADR | 0.28% | 652,357 | $1.2M | Add +4.8% |
| WVE Wave Life Sciences Ltd. | 0.25% | 88,000 | $1.1M | Add +80.2% |
| RNAM Avidity Biosciences Inc. | 0.21% | 31,900 | $928K | Add +24.6% |
| LXEO Lexeo Therapeutics Inc. | 0.21% | 138,115 | $909K | New |
| ALXO Alx Oncology Holdings Inc. | 0.19% | 509,059 | $850K | No change |
| RXRX Recursion Pharmaceuticals-A | 0.18% | 119,000 | $804K | Add +52.6% |
| FDMT 4D Molecular Therapeutics Inc. | 0.15% | 121,000 | $674K | Add +22.8% |
| VAL Valaris Ltd. | 0.14% | 14,182 | $627K | Add +86.3% |
| NOV Nov Inc. | 0.14% | 42,889 | $626K | Add +13.1% |
| AIG American International Group | 0.13% | 8,024 | $584K | No change |
| PFE Pfizer Inc. | 0.13% | 21,978 | $583K | No change |
| AUTL Autolus Therapeutics PLC | 0.12% | 231,674 | $544K | Add +24.8% |
| DYN Dyne Therapeutics Inc. | 0.11% | 20,366 | $480K | Add +35.6% |
| PAAS Pan American Silver Corp. | 0.10% | 21,284 | $430K | Reduce -19.6% |
| URNM Sprott Uranium Miners ETF | 0.09% | 10,276 | $414K | Add +16.0% |
| SA Seabridge Gold Inc. | 0.09% | 35,987 | $411K | Add +12.2% |
| EMX Emx Royalty Corp. filed as EMX RTY CORP | 0.09% | 216,968 | $375K | New |
| FNV Franco-Nevada Corp. | 0.08% | 2,977 | $350K | Reduce -50.9% |
| NE Noble Corp. PLC | 0.08% | 10,525 | $330K | No change |
| NTLA Intellia Therapeutics Inc. | 0.07% | 27,709 | $323K | Add +125.3% |
| URGN Urogen Pharma Ltd. | 0.07% | 27,691 | $295K | New |
| SD Sandridge Energy Inc. | 0.06% | 23,300 | $273K | No change |
| BSAC Banco Santander-Chile-ADR | 0.06% | 13,818 | $261K | No change |
| TSHA Taysha Gene Therapies Inc. | 0.05% | 134,900 | $233K | Add +12.4% |
| HCC Warrior Met Coal Inc. | 0.05% | 4,100 | $222K | No change |
| BTG B2GOLD Corp. | 0.05% | 85,146 | $208K | Reduce -17.8% |
| VZLA Vizsla Silver Corp. | 0.05% | 116,521 | $199K | No change |
| FATE Fate Therapeutics Inc. | 0.03% | 87,000 | $144K | Add +74.0% |
| SBSW Sibanye-Stillwater Ltd.-ADR | 0.03% | 34,040 | $112K | No change |
Other holdings (5): bonds, preferreds, convertibles and warrants · $5.0M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| IONQ.WS Ionq Inc. -CW26 | *W EXP 09/30/202 | 128,001 | $3.9M | New |
| CMPOW Composecure Inc. -CW25 | *W EXP 12/27/202 | 148,853 | $692K | New |
| GCMGW GCM Grosvenor Inc. A -CW25 | *W EXP 11/17/202 | 137,809 | $174K | New |
| GRND.WS Grindr Inc. -26 | *W EXP 11/18/202 | 17,803 | $120K | New |
| IMTXW Immatics NV -CW | *W EXP 07/01/202 | 267,725 | $67K | New |
Total filed on the 13F, all lines: $441.9M.
Portfolio Sells Q3 2024 → Q4 2024
| ASTS Ast Spacemobile Inc. | Reduce -86.4% | 0.54% | −4.80 |
| DDOG Datadog Inc. Class A | Sold out | 0.00% | −1.88 |
| AMD Advanced Micro Devices | Sold out | 0.00% | −1.80 |
| GOOGL Alphabet Inc. Class A | Sold out | 0.00% | −1.65 |
| OXY Occidental Petroleum Corp. | Sold out | 0.00% | −1.04 |
| ROIV Roivant Sciences Ltd. | Reduce -55.5% | 0.58% | −0.81 |
| AXSM Axsome Therapeutics Inc. | Reduce -22.4% | 1.21% | −0.59 |
| MSFT Microsoft Corp. | Reduce -50.0% | 0.48% | −0.59 |
| CPNG Coupang Inc. | Reduce -29.7% | 0.71% | −0.53 |
| ITCI Intra-Cellular Therapies Inc. | Reduce -17.6% | 1.86% | −0.29 |
| C Citigroup Inc. | Sold out | 0.00% | −0.20 |
| ZLAB Zai Lab Ltd.-ADR | Reduce -14.2% | 1.11% | −0.19 |
| BEYOND MEAT INC (BYND 0 03/15/27) | Sold out | 0.00% | −0.18 |
| BTU Peabody Energy Corp. | Sold out | 0.00% | −0.14 |
| AZEK The Azek Co. Inc. | Sold out | 0.00% | −0.13 |
| TILE Interface Inc. | Sold out | 0.00% | −0.13 |
| FNV Franco-Nevada Corp. | Reduce -50.9% | 0.08% | −0.11 |
| OPITQ Office Properties Income Tru | Sold out | 0.00% | −0.09 |
| ZM Zoom Communications Inc. | Sold out | 0.00% | −0.09 |
| ONT Onterris Inc. | Sold out | 0.00% | −0.09 |
| EQX Equinox Gold Corp. | Sold out | 0.00% | −0.09 |
| NGVC Natural Grocers BY Vitamin C | Sold out | 0.00% | −0.08 |
| TDUP Thredup Inc. Class A | Sold out | 0.00% | −0.08 |
| CLH Clean Harbors Inc. | Sold out | 0.00% | −0.08 |
| TWST Twist Bioscience Corp. | Sold out | 0.00% | −0.08 |
| KRNT Kornit Digital Ltd. | Sold out | 0.00% | −0.08 |
| ARHS Arhaus Inc. | Sold out | 0.00% | −0.07 |
| NXE Nexgen Energy Ltd. | Sold out | 0.00% | −0.06 |
| SNOW Snowflake Inc. | Reduce -21.1% | 2.65% | −0.06 |
| QRHC Quest Resource Holding Corp. | Sold out | 0.00% | −0.06 |
| PSTX Poseida Therapeutics Inc. | Sold out | 0.00% | −0.06 |
| NTR Nutrien Ltd. | Sold out | 0.00% | −0.05 |
| WBD Warner Bros Discovery Inc. | Sold out | 0.00% | −0.04 |
| PAAS Pan American Silver Corp. | Reduce -19.6% | 0.10% | −0.04 |
| BTG B2GOLD Corp. | Reduce -17.8% | 0.05% | −0.03 |
| ASAIY Sendas Distribuidora SA | Sold out | 0.00% | −0.02 |
| OTLY Oatly Group AB | Sold out | 0.00% | −0.01 |
| SCWO 374WATER Inc. | Sold out | 0.00% | −0.01 |
| DANIMER SCIENTIFIC INC | Sold out | 0.00% | −0.01 |
| PRQR Proqr Therapeutics NV | Reduce -11.5% | 3.02% | +0.47 |
| SPOT Spotify Technology SA | Reduce -2.7% | 14.85% | +1.18 |
| PLTR Palantir Technologies Inc. Class A | Reduce -22.1% | 6.40% | +2.02 |
| QURE Uniqure NV | Reduce -0.4% | 3.00% | +2.09 |
Portfolio Buys Q3 2024 → Q4 2024
| TSLA Tesla Inc. | Add +1.9% | 20.33% | +6.30 |
| SMR Nuscale Power Corp. | New | 1.48% | +1.48 |
| ARQT Arcutis Biotherapeutics Inc. | New | 1.04% | +1.04 |
| LXEO Lexeo Therapeutics Inc. | New | 0.21% | +0.21 |
| WVE Wave Life Sciences Ltd. | Add +80.2% | 0.25% | +0.15 |
| MRNA Moderna Inc. | Add +103.7% | 0.78% | +0.11 |
| MGTX Meiragtx Holdings PLC | Add +5.2% | 0.31% | +0.09 |
| EMX Emx Royalty Corp. | New | 0.09% | +0.09 |
| URGN Urogen Pharma Ltd. | New | 0.07% | +0.07 |
| RXRX Recursion Pharmaceuticals-A | Add +52.6% | 0.18% | +0.06 |
| KRYS Krystal Biotech Inc. | Add +45.7% | 0.33% | +0.04 |
| VAL Valaris Ltd. | Add +86.3% | 0.14% | +0.04 |
| ARWR Arrowhead Pharmaceuticals Inc. | Add +14.2% | 1.64% | +0.03 |
| NTLA Intellia Therapeutics Inc. | Add +125.3% | 0.07% | +0.01 |
| URNM Sprott Uranium Miners ETF | Add +16.0% | 0.09% | −0.01 |
| TSHA Taysha Gene Therapies Inc. | Add +12.4% | 0.05% | −0.01 |
| NOV Nov Inc. | Add +13.1% | 0.14% | −0.01 |
| FATE Fate Therapeutics Inc. | Add +74.0% | 0.03% | −0.01 |
| DYN Dyne Therapeutics Inc. | Add +35.6% | 0.11% | −0.02 |
| CRSP Crispr Therapeutics AG | Add +15.3% | 0.32% | −0.04 |
| SA Seabridge Gold Inc. | Add +12.2% | 0.09% | −0.04 |
| AUTL Autolus Therapeutics PLC | Add +24.8% | 0.12% | −0.04 |
| MRK Merck & Co. Inc. | Add +20.8% | 1.65% | −0.04 |
| RNAM Avidity Biosciences Inc. | Add +24.6% | 0.21% | −0.08 |
| ABEV Ambev SA-ADR | Add +4.8% | 0.28% | −0.10 |
| FDMT 4D Molecular Therapeutics Inc. | Add +22.8% | 0.15% | −0.11 |
| RCKT Rocket Pharmaceuticals Inc. | Add +34.9% | 1.14% | −0.21 |
| IONS Ionis Pharmaceuticals Inc. | Add +6.4% | 2.13% | −0.36 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +6.5% | 2.49% | −0.86 |
Notes & Other Activity Q3 2024 → Q4 2024
| IONQ.WS Ionq Inc. -CW26 | *W EXP 09/30/202 | New | 128,001 | $3.9M |
| CMPOW Composecure Inc. -CW25 | *W EXP 12/27/202 | New | 148,853 | $692K |
| GCMGW GCM Grosvenor Inc. A -CW25 | *W EXP 11/17/202 | New | 137,809 | $174K |
| GRND.WS Grindr Inc. -26 | *W EXP 11/18/202 | New | 17,803 | $120K |
| IMTXW Immatics NV -CW | *W EXP 07/01/202 | New | 267,725 | $67K |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 61 | $544.2M | TSLA, SHOP, AMD, AMZN, IONS |
| Q1 2026 | 60 | $480.3M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q4 2025 | 57 | $543.1M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q3 2025 | 59 | $556.3M | TSLA, SPOT, SHOP, PLTR, AMZN |
| Q2 2025 | 55 | $463.5M | SPOT, TSLA, SHOP, PLTR, AMZN |
| Q1 2025 | 56 | $383.6M | SPOT, TSLA, SHOP, PLTR, SE |
| Q4 2024 | 59 | $437.0M | TSLA, SPOT, SHOP, AMZN, PLTR |
| Q3 2024 | 82 | $402.0M | TSLA, SPOT, SHOP, AMZN, ASTS |
| Q2 2024 | 85 | $358.2M | TSLA, SPOT, AMZN, SHOP, SNOW |
| Q1 2024 | 75 | $342.7M | SPOT, SHOP, TSLA, AMZN, SNOW |